Health
AstraZeneca vaccine and Guillain-Barré syndrome: There’s minimal cause for concern – Medical Xpress
The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID…
The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID vaccine.
This is an autoimmune disorder, which causes muscle weakness, numbness and tingling. It can be life threatening if it involves the respiratory muscles.
But at this stage, there isn’t cause for serious concern. The six reports are out of 1.8 million doses of the AstraZeneca vaccine administered in Australia so far. This means the…
-
Noosa News22 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
General24 hours agoWhy was Trump the first to address the ideological battle in universities?
-
General17 hours agoIran’s currency at record low as tensions run high
-
General16 hours agoLabor to pledge $2.3 billion to subsidise home batteries